Peripheral neuropathies appeared as a specific COVID-19 symptom in 59% patients18,19. The SARS-CoV-2 virus enters cells via the angiotensin converting enzyme 2 (ACE2) receptor with which the virus spike protein binds20. Here, ACE2 is linked to COVID-19.